Ayala Pharmaceuticals Inc (fka ADXS)

[HVACmaster]

Dew, you said "ADXS can probably wait until 2018 to raise capital. By then, they may have some news (e.g. the AXAL MAA submission in cervical cancer) to lift the share price and make the dilution less onerous." post 215703

Nothing seems to make sense here..the SP should have seen a boost...
The company has 4 major BP partners/ collaborators, almost a year of operating cash, no debt, validated technology, in a cutting edge sector of oncology, multiple upcoming catalysts etc. etc.
And it is awarded a 100mm Market Cap